Skip to content
  • About
  • Contact
  • Contribute
  • What Physicians Say
  • My Book
  • Careers
  • Podcast
  • Speaking
KevinMD.com — Social media's leading physician voice
  • All
  • Physician
  • Burnout
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • All
  • Physician
  • Burnout
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
    • All
    • Physician
    • Burnout
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • About
    • Contact
    • Contribute
    • What Physicians Say
    • My Book
    • Careers
    • Podcast
    • Speaking
KevinMD.com — Social media's leading physician voice
  • All
  • Physician
  • Burnout
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
    • All
    • Physician
    • Burnout
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • About
    • Contact
    • Contribute
    • What Physicians Say
    • My Book
    • Careers
    • Podcast
    • Speaking
  • About Kevin Pho, MD, Founder of KevinMD
  • Aging and dementia: what physicians say, in their own words
  • Artificial intelligence: what physicians say, in their own words
  • Be heard on social media’s leading physician voice
  • Cancer: what physicians say, in their own words
  • Children’s health: what pediatricians say, in their own words
  • Contact Kevin
  • COVID-19: what physicians wrote as it happened
  • Custom enhanced author page pricing
  • Diabetes and obesity: what physicians say, in their own words
  • Direct primary care: what physicians say, in their own words
  • DMCA Policy
  • End of life: what physicians say, in their own words
  • Establishing, Managing, and Protecting Your Online Reputation: A Social Media Guide for Physicians and Medical Practices
  • GLP-1 drugs: what physicians say about Ozempic and its successors, in their own words
  • Heart disease: what physicians say, in their own words
  • Immigration and medicine: what physicians say about immigrant doctors and immigrant patients, in their own words
  • KevinMD influencer opportunities
  • Medical errors: what physicians say, in their own words
  • Medical ethics: what physicians say, in their own words
  • Medical malpractice: what physicians say, in their own words
  • Medical school: what students and physicians say, in their own words
  • Mental health: what psychiatrists and physicians say, in their own words
  • Nursing: what nurses and physicians say, in their own words
  • Opinion and commentary by KevinMD
  • Opioids: what physicians and pain patients say, in their own words
  • Physician burnout speakers to keynote your conference
  • Physician burnout: what physicians say, in their own words
  • Physician Coaching by KevinMD
  • Physician keynote speaker: Kevin Pho, MD
  • Physician personal finance: what physicians say about their own money, in their own words
  • Physician Speaking by KevinMD: a boutique speakers bureau
  • Physician suicide: what physicians say, in their own words
  • Physicians and administrators: what physicians say about who runs medicine, in their own words
  • Primary care physician in Nashua, NH | Kevin Pho, MD
  • Primary care: what physicians say, in their own words
  • Prior authorization: what physicians say, in their own words
  • Privacy Policy
  • Private equity and corporate medicine: what physicians say, in their own words
  • Race and medicine: what physicians say, in their own words
  • Recommended services by KevinMD
  • Residency: what residents and attendings say, in their own words
  • Scope of practice: what physicians, nurse practitioners, and PAs say, in their own words
  • Subscribe to the KevinMD enhanced author page
  • Subscribe to the newsletter
  • Surgeons and surgery: what surgeons say, in their own words
  • Take-home messages: what physicians say when asked to leave one
  • Terms of Use Agreement
  • Thank you for subscribing to KevinMD
  • Thank you for upgrading to the KevinMD enhanced author page
  • The electronic health record: what physicians say, in their own words
  • Vaccines: what physicians say, in their own words
  • Violence against health care workers: what physicians and nurses say, in their own words
  • What physicians say: the KevinMD records
  • Women in medicine: what women physicians say, in their own words
  • Women’s health: what physicians say, in their own words

What do the Fidelity ZERO mutual funds mean for physician investors?

Wall Street Physician, MD
Physician Finance
August 20, 2018
Share
Tweet
Share

Vanguard, Fidelity, and Schwab have been engaging in a fierce competition to claim the mantle as the leading provider of low-cost index funds. As a result, each has aggressively lowered their fees for their index fund offerings over the past few years and advertised their low-cost offerings to investors.

After the latest round of fee reductions in mid-2017, I wrote a post speculating whether it was inevitable that Vanguard, Fidelity, or Schwab would offer a zero expense ratio mutual fund.

That’s right, an index fund that charges no management fee to its investors.

On August 3, 2018, Fidelity made the zero expense ratio index fund a reality, when they began offering the Fidelity ZERO Total Market Index Fund (FZROX), and the Fidelity ZERO International Index Fund (FZILX) to investors.

FZROX gives investors exposure to the total U.S. stock market (through the Fidelity U.S. Total Investable Market Index), while the FZILX tracks a global international stock index (the Fidelity Global ex U.S. Index).

These two funds will allow Fidelity investors to have exposure to the global stock market with zero fees.

Fidelity announced more than just two 0.00% expense ratio index funds

The announcement of zero expense ratio mutual funds was part of a broader reduction in fees by Fidelity.

Lower fees nearly across the board for Fidelity index funds

For three-fund portfolio investors at Fidelity, the Fidelity Total Stock Market Index Fund now has a 0.015% expense ratio (previously 0.035%). The Fidelity U.S. Bond Index Fund (FSITX) now has an expense ratio of 0.025% (previously 0.045%). The Fidelity Total International Index Fund (FTIPX) now has an expense ratio of 0.06% (previously 0.10%).

No minimum investment for Fidelity index funds

If that wasn’t enough good news for Fidelity investors, Fidelity also stopped having minimum investments in order to get the lowest expense ratios. Previously, retail investors had to invest a minimum of $10,000 in a single fund in order to access the lower cost Premium shares, while those who wanted to invest less than $10,000 in an index mutual fund would have had to use the higher-cost Investor shares, which still had a $3,000 minimum. Now, there is no minimum investment for Fidelity’s index funds, and all share classes have the same expense ratio. Previously, Schwab was the only major index fund provider that had no minimum investment for their index mutual funds.

Wider range of commission-free ETFs

ADVERTISEMENT

Vanguard made news in June 2018 when they announced that they would offer over 1,800 ETF’s commission free, including funds from major index ETF providers such as iShares.

Fidelity, as part of their changes, expanded their set of commission-free ETFs to 265 ETFs(iShares and Fidelity) – previously they had fewer than 100 commission-free ETFs. With these ETFs, you can build almost any index portfolio commission-free.

Summary of Fidelity fee changes

To summarize, here are the changes Fidelity made in August 2018 to their fee structure:

  1. Introduction of two zero expense ratio index funds, FZROX and FZILX.
  2. Nearly across-the-board reductions in their existing index fund expense ratios.
  3. Elimination of investment minimums to buy their lowest expense ratio index funds.
  4. Expansion of the number of Fidelity and iShares commission-free ETFs.

What do these changes mean for you?

All index investors will be affected, directly or indirectly, from these Fidelity announcements.

Existing Vanguard and Schwab investors should not switch

I would not recommend existing Vanguard and Schwab investors to move their money to Fidelity to buy the Fidelity ZERO index funds.

The difference between paying 0.00% for Fidelity ZERO index funds and paying 0.03-0.07% at Vanguard or Schwab will not be the difference between a good and a great retirement. In fact, if you liquidate your Vanguard or Schwab index funds from a taxable account, you will hurt yourself by creating capital gains taxes.

Fidelity may be the first company to offer zero expense ratio index funds, but I doubt they will be the last. I expect Vanguard and Schwab to offer their own zero expense ratio index fund in the coming years, especially if the Fidelity ZERO index funds gain traction (which I expect they will).

Fidelity may be the first company to offer zero expense ratio index funds, but I doubt they will be the last.

Even Fidelity investors should not buy FZROX or FZILX in taxable accounts

Even Fidelity investors should not sell investments in their taxable accounts to buy the Fidelity ZERO index funds. As with Vanguard and Schwab, selling shares in a taxable account would incur capital gains taxes. These taxes blunt the compounding power of your investments, which would overwhelm the tiny expense ratio benefit from the new Fidelity ZERO funds.

I would also argue that you should not put new money into these index funds within a taxable account. Mutual funds are slightly tax-inefficient compared to ETFs, because mutual funds have to distribute capital gains, which are taxable, while ETFs do not. This erosion in after-tax returns is likely greater than the difference in expense ratios between the Fidelity ZERO index funds and commission-free iShares ETFs, such as ITOT or IEFA.

Fidelity investors should consider choosing the Fidelity ZERO mutual funds in retirement accounts

In retirement accounts such as a Roth IRA, you can certainly exchange your current index funds for FZROX or FZILX funds, since selling shares within a retirement account do not incur capital gains taxes.

However, it is important to keep perspective that you would save only $15 per $100,000 invested per year in FZROX over FSTVX and $60 per $100,000 invested per year in FZILX over FTIPX or FSGDX.

The Fidelity ZERO index funds track unique indices

Fidelity has created new reference indices for their new Fidelity ZERO mutual funds.

FZROX tracks the Fidelity U.S. Total Investable Market Index, while FZILX tracks the Fidelity Global ex U.S. Index.

I am not concerned about tracking error with the use of internal reference indices, because these indices are publicly available and the reference index return can be tracked by third parties. Both the Fidelity U.S. Total Investable Market Index (used by FZROX) and the Fidelity Global Ex US Index can be tracked on the S&P Dow Jones website, and I don’t anticipate that their tracking error will be significantly different from FSTVX and FTIPX.

Fidelity will gain market share in the short run, especially among new investors

There is something magical about the word free. Even though it was a cut of only a few basis points, Fidelity’s ability to claim a zero expense ratio mutual fund will stick in investor’s minds far more than previous expense ratio cuts in their funds.

I fully expect that this change will help Fidelity gain more market share than Vanguard’s addition of commission-free ETFs. If this happens, expect Vanguard and Schwab to offer their own zero expense ratiio index funds to compete.

Where do expense ratios go from here?

There is speculation on the internet that with zero expense ratio index funds now being offered to investors, a negative expense ratio index fund could be on the horizon. In this scenario, fund companies would actually pay investors to invest in their index funds.

I’m not sure this is the next step in the fee wars. If the Fidelity ZERO index funds succeed, I expect Fidelity to expand their ZERO index fund series to additional asset classes.

At some point, investors will realize that you can get zero or near-zero expense ratio index funds at Vanguard, Fidelity, or Schwab. These companies will need to work on other things like offering even better customer service or improving their website and app interfaces to gain market share.

Conclusion

Investors should welcome the introduction of two zero expense ratio index funds by Fidelity, even if they do not personally invest in them. It is a sign that Vanguard, Fidelity, and Schwab are continuing to undercut each other’s fees in order to attract your investment dollars.

Other than within a Fidelity retirement account, I would not advise selling any current investments to buy these funds. Fidelity investors can consider investing new money into these two new index funds within a retirement account.

“Wall Street Physician,” a former Wall Street derivatives trader , is a physician who blogs at his self-titled site, the Wall Street Physician.

Image credit: Shutterstock.com

Prev

MKSAP: 30-year-old woman with HIV infection

August 20, 2018 Kevin 0
…
Next

This infectious disease physician still finds HIV care rewarding. Here's why.

August 20, 2018 Kevin 0
…

Tagged as: Practice Management

< Previous Post
MKSAP: 30-year-old woman with HIV infection
Next Post >
This infectious disease physician still finds HIV care rewarding. Here's why.

 

ADVERTISEMENT

More by Wall Street Physician, MD

  • 4 reasons why physicians should hire a financial advisor

    Wall Street Physician, MD
  • Investing in the stock market is like playing that game of rock-paper-scissors

    Wall Street Physician, MD
  • 7 sources of financial anxiety for physicians

    Wall Street Physician, MD

Related Posts

  • A physician’s addiction to social media

    Amanda Xi, MD
  • How a physician keynote can highlight your conference

    Kevin Pho, MD
  • Chasing numbers contributes to physician burnout

    DrizzleMD
  • The black physician’s burden

    Naomi Tweyo Nkinsi
  • Why this physician supports Medicare for all

    Thad Salmon, MD
  • Embrace the teamwork involved in becoming a physician

    Nathaniel Fleming

More in Physician Finance

  • Paid for twice

    Physicians paid for G2211 twice. Most never bill it.

    Michael Duben, MD
  • Why physician financial freedom matters more than salary

    Arthur Lazarus, MD, MBA
  • Charitable giving for physicians: 7 strategies for 2026

    Logan Foltz, MD
  • The sweet spot before physician financial independence

    Stanley Liu, MD
  • Negotiating physician compensation works better in groups

    Contract Diagnostics
  • How doctors lose money investing: 6 failure modes

    Harsha Moole, MD
  • Most Popular

  • Past Week

    • Retirement isn’t the end of medicine, it’s a second act [PODCAST]

      The Podcast by KevinMD | Podcast
    • The conflict of interest that discloses as nothing

      Martha Rosenberg | Medications
    • 4 fibromyalgia myths the current evidence doesn’t support

      Kayvan Haddadan, MD | Conditions and Diseases
    • Why exhaustion can make you see things that aren’t there [PODCAST]

      The Podcast by KevinMD | Podcast
    • AI governance in health care has to reach the exam room

      Amanda Heidemann, MD | Health Technology
    • The Pennsylvania measles outbreak and the cost of forgetting

      Christine King, CRNA | Conditions and Diseases
  • Past 6 Months

    • Why CDC opioid guidelines get the overdose data wrong

      Richard A. Lawhern, PhD | Conditions and Diseases
    • Retirement isn’t the end of medicine, it’s a second act [PODCAST]

      The Podcast by KevinMD | Podcast
    • Sensory processing in autism and the brain’s volume control

      Josette Pelatan, PhD | Conditions and Diseases
    • What maternity care deserts cost a town

      Manisha Kaliaperumal | Health Policy
    • Why medicine needs a national physician license now

      Vaishali Popat, MD, MPH | Physician
    • A cold cost $945. The cost of primary care is broken.

      Susan Newman, MD | Physician
  • Recent Posts

    • Why exhaustion can make you see things that aren’t there [PODCAST]

      The Podcast by KevinMD | Podcast
    • 3 reforms to counter wellness influencers in practice

      Farid Sabet-Sharghi, MD | Physician
    • Shift work and circadian rhythms shape the 24/7 workplace

      Deepak Gupta, MD | Conditions and Diseases
    • Paid for twice

      Physicians paid for G2211 twice. Most never bill it.

      Michael Duben, MD | Physician Finance
    • The next child

      Medicaid managed care and the case for mutual stewardship

      Steven Merahn, MD | Health Policy
    • Choosing a limb lengthening surgeon requires accountability

      Hrayr Basmajian, MD | Physician

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 1 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

  • Most Popular

  • Past Week

    • Retirement isn’t the end of medicine, it’s a second act [PODCAST]

      The Podcast by KevinMD | Podcast
    • The conflict of interest that discloses as nothing

      Martha Rosenberg | Medications
    • 4 fibromyalgia myths the current evidence doesn’t support

      Kayvan Haddadan, MD | Conditions and Diseases
    • Why exhaustion can make you see things that aren’t there [PODCAST]

      The Podcast by KevinMD | Podcast
    • AI governance in health care has to reach the exam room

      Amanda Heidemann, MD | Health Technology
    • The Pennsylvania measles outbreak and the cost of forgetting

      Christine King, CRNA | Conditions and Diseases
  • Past 6 Months

    • Why CDC opioid guidelines get the overdose data wrong

      Richard A. Lawhern, PhD | Conditions and Diseases
    • Retirement isn’t the end of medicine, it’s a second act [PODCAST]

      The Podcast by KevinMD | Podcast
    • Sensory processing in autism and the brain’s volume control

      Josette Pelatan, PhD | Conditions and Diseases
    • What maternity care deserts cost a town

      Manisha Kaliaperumal | Health Policy
    • Why medicine needs a national physician license now

      Vaishali Popat, MD, MPH | Physician
    • A cold cost $945. The cost of primary care is broken.

      Susan Newman, MD | Physician
  • Recent Posts

    • Why exhaustion can make you see things that aren’t there [PODCAST]

      The Podcast by KevinMD | Podcast
    • 3 reforms to counter wellness influencers in practice

      Farid Sabet-Sharghi, MD | Physician
    • Shift work and circadian rhythms shape the 24/7 workplace

      Deepak Gupta, MD | Conditions and Diseases
    • Paid for twice

      Physicians paid for G2211 twice. Most never bill it.

      Michael Duben, MD | Physician Finance
    • The next child

      Medicaid managed care and the case for mutual stewardship

      Steven Merahn, MD | Health Policy
    • Choosing a limb lengthening surgeon requires accountability

      Hrayr Basmajian, MD | Physician

Copyright © 2026 KevinMD.com | Powered by Astra WordPress Theme

  • Terms of Use Agreement
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

What do the Fidelity ZERO mutual funds mean for physician investors?
1 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...